| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |